Clerisy Corporation announced today that its Board of Directors has approved a Convertible Debenture offering in order to raise $5,000,000; beginning today, April 9, 2018. The offering will be conducted online utilizing Investor Subscription and Compliance Technology provided by Regulation D Resources of Lakeland, Colorado. The offering will be open to prospective investors who qualify under Regulation D 506(c) rules of the Securities Act. The offering is expected to last up to 180 days, expiring on October 9, 2018.
More information regarding the offering can be found at invest.clerisyhealth.com
About Clerisy Corporation
Clerisy Corp, Rochester New York and Laguna Beach, California; is an internationally focused medical delivery device company that is launching its breakthrough FDA approved NeuroNasal Strip™ product range in the US in mid-2018, followed by additional proprietary products and soft market launches in Canada, China and India.
About Regulation D Resources
Regulation D Resources was formed in 1999 to provide Regulation D Offering preparation and execution support services to entrepreneurs and growing private companies. Headquartered in Lakewood, Colorado, RDR is one of the leading Regulation D private placement advisory services providers in the United States with a comprehensive matrix of services that spans transaction structuring, offering preparation, assistance with SEC and State securities compliance, and access to resources in the capital markets through RDR’s broker-dealer relationships and FINRA broker-dealer resources. Since 1999, RDR has assisted in the preparation of over 4,500 Regulation D exempt private placement offering transactions. For more information on Regulation D Resources please visit: https://regdresources.com/index.php
Safe Harbor Forward-Looking Statements
This release contains ‘forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be ‘forward looking statements. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated.
These securities are being offered under an exemption provided by SEC Regulation D Rule 506(c). Only accredited investors who meet the SEC Regulation D 501 “accredited investor” accreditation standards and who provide suitable verification of accredited status may invest into this Offering.
Any historical performance data represents past performance. Past performance does not guarantee future results;
Current performance may be different than the performance data presented;
The Company is not required by law to follow any standard methodology when calculating and representing performance data;
The performance of the Company may not be directly comparable to the performance of other private or registered funds or companies;
The securities are being offered in reliance on an exemption from the registration requirements, and therefore are not required to comply with certain specific disclosure requirements;
The Securities and Exchange Commission has not passed upon the merits of or approved the securities, the terms of the offering, or the accuracy of the materials.